Hormone Receptor-negative Breast Cancer
📧 Sign up to get email alerts when something new happens for Hormone Receptor-negative Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies [Phase 2]
A Phase 2 trial update from UNC Lineberger Comprehensive Cancer Center for biomarker-driven therapies in breast cancer, currently recruiting…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer [Phase 2]
This Clinical Trials update describes the I-SPY TRIAL, a Phase 2 neoadjuvant breast cancer study using personalized adaptive agents; recruit…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in mTNBC [Phase 1, Phase 2]
Phase 1/2 clinical trial of ZN-c3 combined with carboplatin and pembrolizumab for metastatic triple-negative breast cancer, currently listed…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy [Phase 2]
Phase 2 neoadjuvant breast cancer trial at Fudan University Shanghai Cancer Center evaluating a precision-platform therapy; the study is cur…